Catalysts for $BMRN
15 tracked
Aug 6, 2026
earnings
BIOMARIN PHARMACEUTICAL INC earnings
BIOMARIN PHARMACEUTICAL INC
→
Aug 3, 2026
earnings
BIOMARIN PHARMACEUTICAL INC earnings
BIOMARIN PHARMACEUTICAL INC
→
Apr 30, 2026
earnings
BIOMARIN PHARMACEUTICAL INC earnings
BIOMARIN PHARMACEUTICAL INC
→
Apr 23, 2026
8k filing
$BMRN — BIOMARIN PHARMACEUTICAL INC (BMRN) — 8-K filing
BIOMARIN PHARMACEUTICAL INC
→
Feb 27, 2026
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Nov 20, 2025
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Oct 30, 2025
approval
VIMIZIM (ELOSULFASE ALFA) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Dec 9, 2023
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Nov 20, 2020
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Oct 6, 2020
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Oct 6, 2020
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Oct 6, 2020
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Dec 4, 2019
approval
VIMIZIM (ELOSULFASE ALFA) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
May 24, 2018
approval
PALYNZIQ (PEGVALIASE-PQPZ) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→
Feb 14, 2014
approval
VIMIZIM (ELOSULFASE ALFA) — FDA approval
BIOMARIN PHARMACEUTICAL INC
→